Oxford BioMedica   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Oxford United Kingdom (1995)

Organization Overview

First Clinical Trial
2004
NCT00259844
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Oxford BioMedica